Table 2.
ANOVA of relative viability of MA lines and the pooled controls at G27 and G33 of mutation accumulation
| Source | Generation
|
|||||
|---|---|---|---|---|---|---|
| G27
|
G27, without 18°C treatment
|
G33
|
||||
| df | P | df | P | df | P | |
| Treatment | 2 | >0.6 | 1 | >0.1 | 1 | ∗ |
| Line | 38 | ∗∗∗ | 38 | ∗∗∗ | 34 | ∗∗∗ |
| Block | 5 | >0.5 | 5 | >0.2 | 3 | ∗ |
| T × L | 76 | ∗∗∗ | 38 | >0.3 | 34 | >0.5 |
| T × B | 10 | ∗ | 5 | >0.5 | 3 | ∗ |
| L × B | 190 | >0.9 | 190 | >0.3 | 102 | >0.05 |
| Residual | 563 | 311 | 541 | |||
All effects except treatment were considered random. Main effects were tested using Satterthwaite approximate F-tests (29); interactions were tested over the residual mean squares.
∗, 0.05 < P < 0.01; ∗∗∗, P < 0.001.